TITLE

HIV-1 Prevalence in Selected Tijuana Sub-populations

AUTHOR(S)
Güereña-Burgueño, Fernando; Benenson, Abram S.; Sepúlveda-Amor, Jaime
PUB. DATE
May 1991
SOURCE
American Journal of Public Health;May91, Vol. 81 Issue 5, p623
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To assess the prevalence of HIV-1 (human immunodeficiency virus) infection among high-risk populations in Tijuana, Mexico, HIV-1 antibody status was determined and information on risk behavior was obtained from 1,069 individuals in three high-risk groups. The prevalence of HlV-1 among 415 prostitutes was 0.5 percent; 410 prisoners, 1.2 percent; 233 homosexual/bisexual men, 11.6 percent; and 106 intravenous drug abusers, 1.9 percent. The potential for spread of HIV-1 exists in Tijuana despite the current relatively low seroprevalence of HIV-1.
ACCESSION #
21127808

 

Related Articles

  • WHO GETS AIDS, AND HOW? Fain, Nathan // Advocate;9/15/83, Issue 376, p16 

    Focuses on various issues related to the transmission of AIDS disease and categories of people who are most likely to be infected by it. Chances of finding the AIDS virus in saliva or tears; Role played by blood and semen in the transmission of the disease; Myths about the infectiousness of...

  • UTILIZATION OF HIV ANTIBODY TESTING BY OUT-OF-TREATMENT DRUG USERS. Liebman, Jon; Brooks, Deborah; Bonilla, Louis; Kotranski, Lynne // Journal of Drug Issues;Fall96, Vol. 26 Issue 4, p679 

    This paper examines factors that may influence the utilization of HIV testing by high risk drug users. We interviewed 108 active drug users prior to and subsequent to offering HIV testing. No drug use practices or demographic characteristics, besides gender, were associated with testing. A...

  • HIV/AIDS surging in Eastern Europe. Stephenson, Joan; Stephenson, J // JAMA: Journal of the American Medical Association;12/27/2000, Vol. 284 Issue 24, p3113 

    States that the number of new cases of HIV infection is soaring in Eastern Europe, according to a report by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization. Majority of new infections that are common among injecting drug users; Statistics on infections...

  • Prevalence of HIV antibody in high and low risk groups in England.  // BMJ: British Medical Journal (International Edition);2/18/89, Vol. 298 Issue 6671, p422 

    Investigates the prevalence of HIV antibody in high and low risk groups in England. Tests of incidence of HIV infections in homosexual and bisexual men; Identification of HIV antibody in risk groups; Collection of data on risk factors for HIV infections.

  • Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV-1) Transmission... Bienzle, Dorothee; MacDonald, Kelly S.; Smaill, Fiona M.; Kovacs, Colin; Baqi, Mahin; Courssaris, Barbaram; Luscher, Mark A.; Walmsley, Sharon L.; Rosenthal, Kenneth L. // Journal of Infectious Diseases;7/1/2000, Vol. 182 Issue 1, p123 

    Evaluates couples discordant in their HIV-1 infection status for the presence of protective factors. Infectivity of phytohemagglutinin-stimulated CD4 blasts; Risk factors for HIV infection in seronegative subjects; Lysis of infected CD4 cells and B cell lines by autologous cytotoxic T lymphocytes.

  • Opposition to mandatory HIV testing of pregnant women.  // American Journal of Public Health;Mar1996, Vol. 86 Issue 3, p447 

    The article discusses opposition to mandatory HIV testing of pregnant women in the U.S. The American Public Health Association has consistently advocated voluntary HIV antibody testing with informed consent, education, counseling and referral for services. Studies indicate that the majority of...

  • Stopping AIDS: Now is the Time to Prevent AIDS.  // AIDS Reader (Branden Publishing);1988, p158 

    The article discusses the need to prevent AIDS. Drug abuse and acquired immunodeficiency syndrome are two of the most critical public health problems receiving justified public attention in the U.S. Public health actions must be taken to prevent HIV infections and AIDS during the next decade....

  • HIV seroprevalence surveys in drug treatment centers. Jones, T. Stephens; Allen, David M. // Public Health Reports;Mar/Apr90, Vol. 105 Issue 2, p125 

    Describes a series of HIV seroprevalence survey in drug treatment centers in the United States. Evaluation of prevention programs for intravenous drug users (IVDUs); Determination of the seroprevalence of antibodies to HIV; Determination of the self-reported drug use and sexual behaviors of...

  • HIV-2 Infection: Where Are We Today? Ingole, Nayana A.; Sarkate, Purva P.; Paranjpe, Supriya M.; Shinde, Sameer D.; Lall, Sujata S.; Mehta, Preeti R. // Journal of Global Infectious Diseases; 

    Context: The choice of antiretroviral therapy for HIV-2 differs from that for HIV-1, underscoring the importance of differentiating between the two. Aims: The current study was planned to find out the prevalence of HIV-2 infection at our center and to find out the utility of the current...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics